Gainers
- Tivic Health Systems TIVC stock rose 39.8% to $0.36 during Friday's regular session. The market value of their outstanding shares is at $2.2 million.
- Fortrea Holdings FTRE stock increased by 33.57% to $24.11. The market value of their outstanding shares is at $2.1 billion. As per the press release, Q3 earnings came out today.
- Rigel Pharmaceuticals RIGL stock moved upwards by 32.05% to $20.39. The market value of their outstanding shares is at $358.7 million. As per the news, the Q3 earnings report came out yesterday.
- Inotiv NOTV shares increased by 21.59% to $3.2. The company's market cap stands at $83.1 million.
- Bionomics BNOX stock rose 19.31% to $0.45. The market value of their outstanding shares is at $6.0 million.
- Inhibikase Therapeutics IKT stock increased by 18.7% to $3.3. The company's market cap stands at $217.0 million.
Losers
- ProPhase Labs PRPH stock fell 48.1% to $0.74 during Friday's regular session. The market value of their outstanding shares is at $14.1 million.
- Evolent Health EVH stock fell 41.11% to $14.47. The company's market cap stands at $1.6 billion. The company's, Q3 earnings came out yesterday.
- Maravai LifeSciences MRVI shares fell 37.31% to $4.92. The market value of their outstanding shares is at $695.7 million. As per the press release, Q3 earnings came out yesterday.
- Revance Therapeutics RVNC stock fell 36.6% to $3.67. The company's market cap stands at $381.8 million. As per the press release, Q3 earnings came out yesterday.
- Agilon Health AGL stock declined by 32.08% to $1.9. The market value of their outstanding shares is at $779.7 million. The company's, Q3 earnings came out yesterday.
- AlloVir ALVR stock decreased by 29.23% to $0.69. The market value of their outstanding shares is at $80.1 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in